ST Pharm Co.Ltd (237690) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.036x

Based on the latest financial reports, ST Pharm Co.Ltd (237690) has a cash flow conversion efficiency ratio of -0.036x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-21.16 Billion ≈ $-14.34 Million USD) by net assets (₩593.00 Billion ≈ $401.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ST Pharm Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how ST Pharm Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does ST Pharm Co.Ltd carry for a breakdown of total debt and financial obligations.

ST Pharm Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ST Pharm Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Poya International Co Ltd TWO:5904	0.151x
Stolt-Nielsen Limited LSE:0OHK	0.058x
Cal-Comp Electronics (Thailand) Public Company Limited TW:9105	0.024x
Qingdao NovelBeam Technology Co. Ltd. A SHG:688677	0.013x
Suzhou Nanomicro Technology Co Ltd SHG:688690	0.014x
Super Retail Group Ltd AU:SUL	0.116x
CETC Digital Technology Co Ltd SHG:600850	0.020x
Zhejiang Huatie Constr Safety SHG:603300	0.167x

Annual Cash Flow Conversion Efficiency for ST Pharm Co.Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of ST Pharm Co.Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of ST Pharm Co.Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩593.00 Billion ≈ $401.87 Million	₩13.99 Billion ≈ $9.48 Million	0.024x	-89.16%
2024-12-31	₩502.99 Billion ≈ $340.87 Million	₩109.45 Billion ≈ $74.17 Million	0.218x	+6384.31%
2023-12-31	₩386.91 Billion ≈ $262.20 Million	₩1.30 Billion ≈ $879.90K	0.003x	-83.89%
2022-12-31	₩337.63 Billion ≈ $228.81 Million	₩7.03 Billion ≈ $4.76 Million	0.021x	-7.48%
2021-12-31	₩322.97 Billion ≈ $218.87 Million	₩7.27 Billion ≈ $4.93 Million	0.023x	+131.75%
2020-12-31	₩295.33 Billion ≈ $200.14 Million	₩-20.93 Billion ≈ $-14.19 Million	-0.071x	+30.09%
2019-12-31	₩300.96 Billion ≈ $203.95 Million	₩-30.52 Billion ≈ $-20.68 Million	-0.101x	-412.25%
2018-12-31	₩331.57 Billion ≈ $224.70 Million	₩10.77 Billion ≈ $7.30 Million	0.032x	-79.06%
2017-12-31	₩351.08 Billion ≈ $237.92 Million	₩54.44 Billion ≈ $36.89 Million	0.155x	-4.35%
2016-12-31	₩313.24 Billion ≈ $212.28 Million	₩50.78 Billion ≈ $34.41 Million	0.162x	-42.38%
2015-12-31	₩127.33 Billion ≈ $86.29 Million	₩35.82 Billion ≈ $24.28 Million	0.281x	--

About ST Pharm Co.Ltd

KQ:237690 Korea Pharmaceuticals

Market Cap

$1.93 Billion

₩2.85 Trillion KRW

Market Cap Rank

#6412 Global

#168 in Korea

Share Price

₩152500.00

Change (1 day)

-6.67%

52-Week Range

₩71600.00 - ₩168700.00

All Time High

₩168700.00